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Purpose: Microphthalmia and anophthalmia are at the severe end of the spectrum of abnormalities in ocular development.
A few genes (orthodenticle homeobox 2 [OTX2], retina and anterior neural fold homeobox [RAX], SRY-box 2 [SOX2],
CEH10 homeodomain-containing homolog [CHX10], and growth differentiation factor 6 [GDF6]) have been implicated
mainly in isolated micro/anophthalmia but causative mutations of these genes explain less than a quarter of these
developmental defects. The essential role of the LIM homeobox 2 (LHX2) transcription factor in early eye development
has recently been documented. We postulated that mutations in this gene could lead to micro/anophthalmia, and thus
performed molecular screening of its sequence in patients having micro/anophthalmia.
Methods: Seventy patients having non-syndromic forms of colobomatous microphthalmia (n=25), isolated
microphthalmia (n=18), or anophthalmia (n=17), and syndromic forms of micro/anophthalmia (n=10) were included in
this study after negative molecular screening for OTX2, RAX, SOX2, and CHX10   mutations.  Mutation  screening   of 
was performed by direct sequencing of the coding sequences and intron/exon boundaries.
Results: Two heterozygous variants of unknown significance (c.128C>G [p.Pro43Arg]; c.776C>A [p.Pro259Gln]) were
identified in LHX2 among the 70 patients. These variations were not identified in a panel of 100 control patients of mixed
origins. The variation c.776C>A (p.Pro259Gln) was considered as non pathogenic by in silico analysis, while the variation
c.128C>G (p.Pro43Arg) considered as deleterious by in silico analysis and was inherited from the asymptomatic father.
Conclusions: Mutations in LHX2 do not represent a frequent cause of micro/anophthalmia.
Microphthalmia and anophthalmia are at the severe end
of the spectrum of abnormalities in ocular development. The
combined occurrence rate for these two malformations is
estimated between 3 and 30 per 100,000 births [1]. Mutations
in several genes have been found in syndromic and non-
syndromic anophthalmia. Heterozygous mutations in SRY-
box 2 (SOX2) account for approximately 10% of
anophthalmias [2,3]. Growth differentiation factor 6 (GDF6)
mutations may account for up to 8% of micro/anophthalmia
[4,5]. Other genes have been identified as causing isolated
anophthalmia or microphthalmia in humans (orthodenticle
homeobox 2 [OTX2], retina and anterior neural fold
homeobox [RAX], and CEH10 homeodomain-containing
homolog [CHX10]) [1,3,6-8]. These latter are implicated in a
very small proportion of affected individuals, implying wide
genetic heterogeneity to match the phenotypic variability.
The LIM homeobox 2 (LHX2) transcription factor has
been shown to be essential for mammalian eye development
and mice deficient in functional Lhx2 protein have been
shown to display anophthalmia [9]. More recent studies on
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mouse models have demonstrated that, during eye
development, Lhx2 regulates levels and/or expression
patterns of Rax, Chx10, Sox2, and Otx2  [10,11], them-
selves involved in human micro/anophthalmia.
We hypothesize that mutations in LHX2 could lead to
severe eye developmental disorders including micro/
anophthalmia. We thus performed molecular analysis in 70
micro/anophthalmia patients for whom previous molecular
analysis of genes implicated in isolated micro/anophthalmia
(SOX2, OTX2, RAX, and CHX10) failed to identify any
causative mutation.
METHODS
Patients: Seventy patients having non-syndromic forms of
colobomatous microphthalmia (n=25), isolated
microphthalmia (n=18), or anophthalmia (n=17), or
syndromic forms of micro/anophthalmia (n=10) were
included in this study. Their informed consent was obtained
beforehand, according to French law. Micro/anophthalmia
was considered as syndromic when the patient presents at least
one other non ocular malformation (in our patients, associated
malformations were intestinal atresia multiple, corpus
callosum agenesis, heart malformation, deafness, Dandy
Walker malformation, labiopalatal cleft, sexual ambiguity,
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hypospadias, arthrogryposis, and choanal atresia). All patients
included had undergone molecular analysis of SOX2, OTX2,
RAX, CHX10. Direct sequencing of the coding regions and
exon/intron boundaries and exclusion of exonic
rearrangement by Quantitative Multiplex PCR of Short
fluorescent Fragments (QMPSF) of these genes failed to
identify any causative mutation in these patients.
Techniques: The 5 exons of the LHX2 gene were amplified by
PCR using primers deduced from the LHX2 genomic
sequence. Primer pairs and PCR conditions used are
summarized in Table 1. Products were amplified in 25 µl
reactions containing 50 ng genomic DNA, 1× PCR buffer,
0.2 mM dNTPs, 2 mM MgCl2, 100 nM forward primer, 100
nM reverse primer, and 1 U of Taq polymerase. Betaine (1 M)
was added in PCR mix for exons 1 and 2. All PCR reactions
were performed with a 5 min 95 °C denaturing step, followed
by 14 cycles of 95 °C for 30 s, annealing temperature for 30
s (70 °C to 62 °C, −0.5 °C/cycle) and 72 °C for 45 s, followed
by 20 cycles of 95 °C for 30 s, 62 °C for 30 s, and 72 °C for
45 s with a final elongation step of 72 °C for 7 min. PCR
amplifications were subsequently purified using QIAquick
Gel Extraction kit (QIAGEN SA, Courtaboeuf, France), and
both forward and reverse strands were sequenced using Big
Dye DNA sequencing kit (Applied Biosystems, Warrington,
UK). Reactions were analyzed in an ABI3100 sequencer
(Applied Biosystems). Sequence variations were numbered
with the adenine of the ATG initiation codon as the first
nucleotide (the LHX2 GenBank accession number was
NM_004789.3).
RESULTS AND DISCUSSION
LHX2 encodes the transcription factor LHX2 which is highly
conserved across species [12] and has recently been
demonstrated to play a critical role in eye development [10,
11]. LHX2 is required to induce or maintain expression of
genes required at the early optic vesicle stage for
regionalization, establishment of retinal dorsoventral polarity,
retinal progenitor cell properties, and lens specification [11].
LHX2 has thus been proposed to link the multiple pathways
needed for transition of the optic vesicle to the optic cup
[11]. Mice lacking Lhx2 expression display anophthalmia, and
this transcription factor has been involved in regulation of
expression levels and/or expression patterns of genes already
involved in micro/anophthalmia (SOX2,RAX,CHX10, and
OTX2) during eye development [10,11]. We hypothesized that
mutations in LHX2 may be involved in human micro/
anophthalmia, and thus molecular screening of this gene in 70
micro/anophthalmic patients was performed.
Molecular analysis allowed identification of three
sequence variations. We observed presence of the described
TABLE 1. PRIMERS USED FOR LHX2 MOLECULAR ANALYSIS.
Exon Forward primer Reverse primer Product length (bp)
1 TGAGGCGGGGGGCAAGCCCT GGAGCCACCGGCCTTGCATT 333
2 ATGTCCTGGCAGCCCCCTCC GCCAAACTGTAAGACTGTGCCTG 404
3 CCGTGTGTTCCCACAGCCCC CCGTCGAGGCCGCACACTTT 505
4 TGGGTGGGGCGAGTGTGGAT GTCCTTCCAAGGCCCACGGC 369
5 CTCACCAGCCCTTCCCTGTC ATGTGGTTAGTTAGTTGCTC 445
Figure 1. Missense variations identified in this cohort, and conservation of involved amino-acid among species. Electropherograms showing
the c.128C>G (p.Pro43Arg; A) and the c.776C>A (p.Pro259Gln; 
C
) LHX2 variations. Alignment of part of LHX2 proteins from human,
mouse, Xenopus and zebrafish, showing conservation of proline 43 (
B
, boxed) in these species, and absence of proline 259 conservation (D,
boxed), which is replaced by a glutamine in Xenopus and zebrafish.
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SNP c.783G>C (p.Pro261Pro) either in a heterozygous or
homozygous state in 42 out of 70 patients. In addition, two
variants of unknown significance were identified. The
heterozygous c.128C>G (p.Pro43Arg; Figure 1A) was
identified in an anophthalmic patient originating from Libya
for whom no other sequence variation was found. Pro43
amino-acid is conserved among species (Figure 1C) and is
located closely to the conserved LIM domain 1 of the protein.
This variation was not identified in a panel of 200 control
chromosomes of mixed geographical origins (Caucasian,
African, and Asian), and was considered as probably
damaging by in silico analysis (PolyPhen and SIFT software).
However, familial study has shown that this variation was
inherited from his father who harbors a normal ocular
examination. Thus, this heterozygous variation may be non-
pathogenic, even if dominant inheritance with incomplete
penetrance can not be totally ruled out. We cannot also
exclude presence of an undetected maternally inherited
mutation (e.g located in intronic or promoter region
sequences, or an exonic rearrangement) fitting with an
autosomal recessive inheritance. In a French patient with
colobomatous microphthalmia, we identified the
heterozygous variation c.776C>A (p.Pro259Gln; Figure 1B).
This variation was not identified in a panel of 200
chromosomes from Caucasian controls. No sample was
available for his parents, and familial segregation study was
not possible. Additionally, there are arguments against the
implication of this variation in the patient’s ocular phenotype.
First, Pro259 is not a conserved amino-acid among species
(Figure 1D), and a glutamine is present at this position in
several distant species including Xenopus, Chicken, and Fugu
Fish [12]. Second, this variation was considered as non
damaging by in silico analysis (PolyPhen and SIFT software).
Thus, we consider this variant as probably non deleterious.
Molecular analysis failed to identify any other sequence
variation in the remaining 68 patients included in this study.
In conclusion, although mutations in LHX2 may
nevertheless be implicated in some micro/anophthalmia
patients, our results suggest that such sequence variations are
not a frequent cause of micro/anophthalmia. Molecular basis
of these ocular malformations remains still poorly understood
and further work remains to be achieved to identify new
micro/anophthalmia genes.
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